Jupiter Neurosciences closes $2 million registered direct offering May 26, 2026 12:00PM
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering May 26, 2026 12:00PM
Jupiter Neurosciences secures $100M term sheet for MDMA therapeutic rights May 20, 2026 07:44AM
Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit May 4, 2026 11:30AM
Jupiter Neurosciences (JUNS) files $100M mixed shelf Apr 16, 2026 06:12AM


Apr 13, 2026 08:00PM Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14
Jan 28, 2026 06:02AM Jupiter Neurosciences targets GLP-1 users with Nugevia supplement line
Jan 27, 2026 10:45AM Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Dec 16, 2025 10:31AM Jupiter Neurosciences receives FDA clearance for Parkinson's trial
Dec 2, 2025 04:15PM Jupiter Neurosciences to Participate in NobleCon21
Oct 27, 2025 08:30AM Jupiter Neurosciences secures up to $20 million financing deal
Jul 23, 2025 08:00AM Jupiter Neurosciences reports 9x bioavailability boost for resveratrol drug
Jul 10, 2025 04:05PM Jupiter Neurosciences regains NASDAQ compliance after stock price recovery
Jun 30, 2025 03:15PM Jupiter Neurosciences (JUNS) Showcases Nugevia PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery
Jun 27, 2025 08:02AM Jupiter Neurosciences (JUNS) Unveils Nugevia GLO
Jun 9, 2025 07:02AM Jupiter Neurosciences (JUNS) Launches Nugevia
Apr 8, 2025 08:06AM Jupiter Neurosciences (JUNS) Highlights Upcoming Milestones in Shareholder Letter
Mar 7, 2025 11:10AM Alliance Entertainment and Jupiter Neurosciences Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Mar 4, 2025 08:00AM Jupiter Neurosciences (JUNS) and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products
Feb 4, 2025 09:25AM Jupiter Neurosciences (JUNS) Addresses Market Volatility
Feb 3, 2025 08:01AM Jupiter Neurosciences (JUNS) Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial
Jan 30, 2025 08:02AM Jupiter Neurosciences (JUNS) Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
Jan 13, 2025 08:10AM Jupiter Neurosciences (JUNS) Announces Strategic Focus on NLRP3 Pathway in Future JOTROL Trials
Dec 19, 2024 10:28AM Greenridge Capital Starts Jupiter Neurosciences (JUNS) at Buy
Sep 4, 2024 06:18AM Jupiter Neurosciences (JUNS) Files for 2.75M Share IPO at $4-$5/sh